Bicycle Therapeutics
Bicycle Therapeutics develops precision-guided therapeutics designed to penetrate deep into tissues to target intractable cancers and solid tumors. The company utilizes a proprietary molecule technology to create medicines for oncology and other therapeutic areas including cardiovascular, respiratory, and central nervous system diseases. Their business model includes developing an internal pipeline and establishing collaborative relationships with pharmaceutical partners and academic institutions.
Funding summary
- Total raised
- €512.0M
- Funding rounds
- 1
- Exit
- ipo
- Exit value
- €173.4M
Investors in Bicycle Therapeutics
Investors on record for Bicycle Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Bicycle Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors